Original Research ARTICLE
Monoclonal Antibody Preparation and Epitope Identification for Brucella melitensis Elongation Factor Tu
- 1Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Shandong Agricultural University, Tai’an, China
- 2Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, Tai’an, China
- 3Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, Tai’an, China
Elongation factor thermo-unstable (EF-Tu), an abundant multifunctional protein, is pivotal during protein synthesis and is an important antigen. Few studies have addressed the role of this protein in Brucella species, and the epitopes of this protein have not been reported. Here, we describe a monoclonal antibody (McAb), BD6, for EF-Tu in Brucella melitensis. Using western blotting involving a series of partially overlapping recombinant EF-Tu truncation peptides, a novel linear B-cell epitope, 110QTREHIL116 (EF), was identified. Alanine-scanning mutagenesis revealed that residues Q110, T111, R112, I115, and L116 were core residues involved in recognition. Sequence alignment suggested that the epitope peptide was conserved among bacterial species but differed by one amino acid residue (I115) from the host sequence. The epitope peptide was recognized by sera from B. melitensis-infected mice, and while recombinant epitope peptide induced a strong humoral immune response, the corresponding mouse peptide, QTREHLL, did not. These results suggested that I115 may be the key residue for the host immune system to distinguish between bacterial and self epitope EF sequences. Indirect immunofluorescence and western blotting assays showed that epitope peptide could be used in Saccharomyces cerevisiae, human embryonic kidney cell (HEK-293), and chicken fibroblast cell (DF1) expression systems and immunoprecipitation assay. Together, our results suggested that the McAb BD6 is a useful tool for further investigation of the potential functions of the EF-Tu protein in pathogen-host interactions, and that the epitope tag may be useful for application as a novel affinity tag to identify other bacterial pathogens, especially convenient for the identification of intracellular bacteria.
The protein elongation factor thermo-unstable (EF-Tu) is abundant both in prokaryotic and eukaryotic cells, reaching concentrations almost ten times higher than that of ribosomes under rapid growth conditions (Furano, 1975). EF-Tu is a cytoplasmic protein and plays a central role in protein synthesis by mediating the transport of aminoacyl-tRNA to the codon recognition site of ribosomes (Kaziro, 1978). However, recent studies have suggested that the EF-Tu proteins of several prokaryotic plant and animal pathogens are exposed on the cell surface (Balasubramanian et al., 2008; Barel et al., 2008; Wolff et al., 2013; Amimanan et al., 2017) and that surface-located EF-Tu proteins play a pivotal role in bacterial adhesion, invasion, and host immune evasion (Jonak, 2007; Kunert et al., 2007; Mohan et al., 2014; Amimanan et al., 2017). Brucella melitensis is an important zoonotic pathogen. In Yang et al. (2011), identified B. melitensis EF-Tu as a candidate antigen using an immunoproteomics approach. Wang et al. (2013) then found that EF-Tu-encoding gene tuf2 plays an important role in the virulence attenuation of B. melitensis vaccine strain M5-90. The specific virulence mechanism and other functions of the EF-Tu protein remain unclear, and molecular tools needed to carry out an analysis, including a monoclonal antibody (McAb) targeting the Brucella EF-Tu protein, have yet to be developed.
McAbs were first reported in 1975 (Kohler and Milstein, 1975) and have revolutionized many areas of vaccine development and protein discovery. For example, McAbs are widely used in disease diagnosis, functional protein studies, and in monoclonal antibody-based therapies, among many other applications (Kivi et al., 2016). Epitope mapping using McAbs provides a platform for studying antigen structure and developing epitope vaccines (Tissot et al., 2010). Together with their corresponding epitopes, McAbs also have wide-ranging experimental applications, including western blot analysis, enzyme-linked immunosorbent assays (ELISA), co-immunoprecipitation, endogenous localization, and affinity purification (Kimple et al., 2013; Liu et al., 2016). In the present study, we generated an anti-B. melitensis EF-Tu mouse McAb, identified its linear B-cell epitope, and examined the antigenicity of the epitope peptide. To the best of our knowledge, our findings mark the first B-cell linear epitope in the EF-Tu protein from B. melitensis and provide a tool for studying the function and mechanism of B. melitensis EF-Tu.
Materials and Methods
All the experiments were conducted at biosafety level 1 laboratories, strictly in accordance with laboratory biosafety regulations. The study protocol and all animal experiments were approved by the Animal Care and Use Committee of Shandong Agricultural University, Tai’an, China (SCUC permission no. SDAUA-2015-015), and were performed in strict accordance with experimental animal regulation ordinances defined by China National Science and Technology Commission. The female BALB/c mice were housed in a suitable habitat, without psychological trauma or unnecessary pain throughout the study. Mice were housed in 800-cm2 plastic cages (five mice per cage) under a normal light-dark cycle and provided with standard laboratory food and water ad libitum. All mice were euthanized with an overdose of isoflurane (5%). Exposure to isoflurane (5%) was continued for at least 1 min after breathing had ceased.
Strains, Cell Lines, and Experimental Animals
The vectors pET30a-EF-Tu (from our own collection) and pGEX-6p-1 (TaKaRa, Dalian, China) were used to obtain recombinant His-tagged and glutathione S-transferase (GST)-tagged B. melitensis EF-Tu proteins, respectively. Escherichia coli Top10 cells (Invitrogen, Carlsbad, CA, United States) were used for all cloning experiments, while E. coli BL21(DE3) (Invitrogen) was used for the protein expression assay. Anti-EtMIC2 (microneme 2 protein from the protozoan parasite Eimeria tenella) McAbs were prepared in our laboratory as described previously (Liu et al., 2014). Mouse serum infected with B. melitensis artificially was kindly provided by Prof. Bu, Harbin Veterinary Research Institute. SP20 mouse myeloma cells were purchased from the American Type Culture Collection (Manassas, VA, United States) and cultured in Gibco Dulbecco’s modified Eagle’s medium (Thermo Fisher Scientific, Waltham, MA, United States) supplemented with 10% (w/v) fetal bovine serum (FBS; Thermo Fisher Scientific). Female BALB/c mice aged 4–5 weeks were purchased from Vital River Laboratories (Beijing, China).
Preparation of Recombinant Proteins
Brucella melitensis EF-Tu-encoding gene tuf2 was amplified from pET30a-EF-Tu using primers BM-GST-F (5′-TTG GATCCATGGCAAAGAGTAAGTTTGAAC-3′) and BM-GST-R (5′-TTCTCGAGTTACTCGATGATCGAC-3′) and cloned into vector pGEX-6p-1, generating recombinant plasmid pGEX-EF-Tu. pGEX-EF-Tu and pET30a-EF-Tu were then separately transformed into electrocompetent E. coli BL21(DE3) cells. Following induction with isopropyl-β-D-thiogalactopyranoside, recombinant proteins were purified using a His-Bind Purification Kit (TransGen Biotech, Beijing, China) or a ProteinIso GST Resin Kit (TransGen Biotech) and confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS–PAGE) analysis. Protein concentrations were determined using a Bio-Rad Protein Assay Kit (Bio-Rad Laboratories, Hercules, CA, United States) as per the manufacturer’s instructions.
Generation of Hybridoma Cells
Hybridoma cells were produced as per the method described by Liu et al. (2014). Briefly, mice were immunized subcutaneously with purified His-EF-Tu protein (50 μg/mouse) suspended in Freund’s complete adjuvant (FCA; Sigma-Aldrich, St. Louis, MI, United States). Following two additional immunizations with the same dose of Freund’s incomplete adjuvant (FIA; Sigma, United States) at 2-week intervals, immunoreactivity against EF-Tu was validated and a final booster immunization of purified His-EF-Tu protein (100 μg/mouse) was given without adjuvant. Four days after booster immunization, mice were euthanized, their spleens removed, and spleen cells isolated using standard techniques. The spleen cells were fused with SP20 myeloma cells to generate hybridomas as described by Hadji-Ghasemi et al. (2003). The immunoglobulin subclass was determined using an IsoStrip Mouse Monoclonal Antibody Isotyping Kit (Sigma-Aldrich) as per the manufacturer’s instructions. Selected cell clones were then cultured in the peritoneal cavities of BALB/c mice to obtain ascetic fluid. McAbs were then purified from the resulting ascites fluid using a Protein G Spin Purification Kit (Pierce Biotechnology, Rockford, IL, United States) and stored at −80°C until further use. The resulting anti-B. melitensis EF-Tu McAb was named BD6.
Immunofluorescent Staining of Yeast Surface-Displayed EF-Tu
Yeast surface display of B. melitensis EF-Tu protein was used to determine the specificity of BD6 as per the method described by Sun et al. (2014b). Briefly, B. melitensis EF-Tu-encoding gene tuf2 was cloned into pCTCON2 using the primers described above. The recombinant plasmid was transformed into Saccharomyces cerevisiae cells for the display of B. melitensis EF-Tu on the cell surface. Resulting yeast cells displaying EF-Tu were incubated with BD6 (1:1,000) as the primary antibody, with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG [H + L] (Cowin Biotech, Beijing, China) then used as secondary antibody. After three washes with PBS, the yeast cells were resuspended in PBS and observed under a fluorescence microscope (TE-2000-S; Nikon, Tokyo, Japan). Yeast cells labeled with anti-EtMIC2 McAb acted as controls for non-specific antibody binding. S. cerevisiae transformed with empty plasmid was stained in the same way and used as a negative control.
Identification of the Position of the Linear Epitope
To map the linear epitope, a GST-tagged fragment of the B. melitensis EF-Tu gene was designed and expressed in E. coli BL21(DE3). Three overlapping fragments of the gene were amplified using specific primers (Supplementary Table 1) and cloned into vector pGEX-6p-1, generating recombinant plasmids pGEX-EF-Tu-1-1, pGEX-EF-Tu-1-2, and pGEX-EF-Tu-1-3. The recombinant proteins were expressed and purified as described above and then analyzed by western blotting with BD6 as primary antibody and horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (Cowin Biotech) as secondary antibody.
Based on the results of the western blot, two fragments (EF-Tu-2-1 and EF-Tu-2-2) of the positive region were amplified (Supplementary Table 1), cloned, and expressed as described above to determine the position of the epitope. Recombinant proteins were detected by western blotting using BD6 as described above. A further five fragments (EF-Tu-3-1, EF-Tu-3-2, EF-Tu-3-3, EF-Tu-3-4, and EF-Tu-3-5) were then amplified (Supplementary Table 1), expressed, and examined in the same way. Lastly, four fragments (EF-Tu-4-1, EF-Tu-4-2, EF-Tu-4-3, and EF-Tu-4-4) were designed by reducing the number of amino acids one by one on each side until the accurate position of the epitope was determined (Supplementary Table 1). The epitope was referred to as EF.
The key amino acid residues for antigen binding to the McAb were identified by western blotting and yeast expression. For western blotting, a series of GST-fusion mutant peptides where individual residues of the epitope peptide were substituted with alanine were designed (Supplementary Table 2). The mutant peptides were then expressed and analyzed by western blotting using anti-EF-Tu McAb as the primary antibody.
Overlap PCR was used to generate the mutant peptides. Briefly, to generate a Q110A substitution in the EF-Tu-encoding gene, two overlapping gene fragments were generated by PCR using primers P-EF-Tu-F1/P-EF-Tu-(110)-R1 and P-EF-Tu-(110)-R2/P-EF-Tu-R1 (Supplementary Table 3), respectively. The mutant gene was then generated by overlap PCR using the previous PCR product as template and P-EF-Tu-F1/P-EF-Tu-R1 as primers. The remaining mutant EF-Tu genes containing single amino acid substitutions were obtained in the same way using primers listed in Supplementary Table 3. The mutant EF-Tu proteins were then displayed on the surface of S. cerevisiae cells as described above. Following incubation with BD6 as the primary antibody and FITC-conjugated goat anti-mouse IgG [H + L] as the secondary antibody, yeast cells with bound antibody were detected by fluorescence microscopy and using a BD LSRFortessa cell analyzer (BD Biosciences, Franklin Lakes, NJ, United States).
Analysis of Biological Information
The spatial distribution of the identified epitope in the B. melitensis EF-Tu protein was analyzed by mapping the epitope locations on a 3-D model using the SWISS-MODEL online server. The antigenic index of EF-Tu was analyzed using PROTEIN software (DNASTAR Inc., Madison, WI, United States).
Mouse Immunization Assays
Glutathione S-transferase-tagged B. melitensis and mouse recombinant EF proteins were obtained as described above. To assess the level of the EF fusion proteins to induce humoral immunity, 20 female BALB/c mice were divided into four groups (n = 5 mice per group). At 4 weeks of age, the mice were immunized subcutaneously with 50 μg of GST-EF (B. melitensis), GST-EF (Mouse), or purified GST protein, or with 100 μL of PBS, in FCA. At 2 weeks post-immunization, the mice were given a booster immunization using the same dose of protein in FIA. On the day of the booster immunization and at 7 days post-booster immunization, the levels of anti-EF (B. melitensis/mouse) synthetic peptide serum antibodies were estimated by enzyme-linked immunosorbent assay (ELISA).
Dot Blot Assays
Mouse serum samples infected with B. melitensis were detected by dot blot as described by Sun et al. (2019). Briefly, approximately 500 ng of synthetic peptide was spotted onto nitrocellulose membranes (Millipore, Bedford, MA, United States) in the center of the grid. After blocking with 5% (w/v) bovine serum albumin in TBST buffer, membranes were incubated with serum samples or anti-EF-Tu McAb (positive control) as the primary antibody for 1 h at 37°C. The membranes were then washed three times with TBST buffer and incubated with HRP-conjugated goat anti-bovine IgG (H + L; Sigma-Aldrich) for 1 h at 37°C. After washing, enhanced chemiluminescence reagent was used to visualize the reaction.
Expression of Heterogenous Genes Fused With an EF Tag
To examine the effects of an epitope EF tag in a yeast expression system, EtMIC2 was used as a foreign gene to be displayed in yeast cells. Epitope EF tag was fused to the C-terminus of EtMIC2 in vector pCTCON2-EtMIC2 (Sun et al., 2014a). Yeast cells were then transfected with pCTCON2-EtMIC2 or pCTCON2-EtMIC2-EF and detected by indirect immunofluorescence using anti-EtMIC2 McAb. The expression of EtMIC2-EF and EtMIC2 on yeast cells was then quantified by flow cytometry as described by Sun et al. (2014a).
To examine the effects of a BD6 epitope tag in mammalian and avian expression systems, an epitope EF tag was fused to the C-terminus of EGFP in vector pEGFP-C1. The recombinant plasmid was transfected into human embryonic kidney cells (HEK-293) and chicken fibroblasts (DF1) as described previously (Liu et al., 2016). At 24 h post-transfection, cells were observed by fluorescence microscope, while cell lysates were collected as described previously (Liu et al., 2016) and analyzed by western blotting.
Immunoprecipitation (IP) of Transiently Expressed EGFP-BD6 Epitope
To examine the specificity of BD6 for immunoprecipitation, 500 μL of protein extract from EGFP-EF-expressing HEK-293 cells was mixed with 2 μg of BD6 and incubated for 2 h at 4°C. A 25-μL volume of Protein G Sepharose (GE Healthcare Life Sciences, Pittsburgh, PA, United States) was added to the supernatant and incubated for 2 h at 4°C. The supernatant was then discarded after centrifugation and the Sepharose was washed three times. Proteins were analyzed by western blotting using anti-GFP McAb as the primary antibody.
Generation and Identification of Anti-EF-Tu McAb BD6
To obtain anti-EF-Tu McAbs, His-tagged and GST-tagged EF-Tu proteins were expressed and purified. SDS–PAGE analyses revealed that the two recombinant proteins were successfully purified and had the correct molecular mass (Figure 1A). After fusion and screening, a hybridoma cell line stably expressing and secreting antibodies against GST-EF-Tu was obtained. The resulting McAbs were designated BD6. Subclass detection showed that BD6 belonged to the IgG1 subclass of antibodies that express a κ light chain.
Figure 1. Identified McAbs that recognize EF-Tu protein. (A) SDS–PAGE analysis of purified His-Tag and GST-Tag Brucella melitensis EF-Tu protein. (B) Analysis of specificity of McAb BD6 by yeast surface displays. (a) Yeast cells displaying B. melitensis EF-Tu protein were immunofluorescently labeled with McAb BD6; (b) yeast cells with empty plasmid were immunofluorescently labeled with McAb BD6; (c) yeast cells displaying B. melitensis EF-Tu protein with anti-EtMIC2 protein McAb as a non-specific binding McAb control.
Because naturally expressed protein is the best substrate for identifying McAbs (Liu et al., 2014; Chen et al., 2018), the yeast surface display technique was used to test the specificity of BD6. Indirect immunofluorescence assays showed strong immunofluorescence on the surface of yeast cells expressing B. melitensis EF-Tu (Figure 1Ba) but not on those transformed with the empty vector (Figure 1Bb). Additionally, no fluorescence was observed for B. melitensis EF-Tu-expressing yeast cells labeled with non-specific antibody (Figure 1Bc). The cell line specifically secreting McAb BD6 has been stored at the China General Microbiological Culture Collection Center (no. 10952).
Identification of the Epitope Recognized by BD6
To accurately map the position of the BD6 epitope, 10 overlapping fragments of the EF-Tu-encoding gene were amplified (Figure 2A). The corresponding amino acid sequences are shown in Supplementary Table 4. Following expression in E. coli BL21(DE3), western blotting showed that BD6 reacted with fragments EF-Tu-1-1, EF-Tu-1-2, EF-Tu-2-1, and EF-Tu-3-5, but not with EF-Tu-1-3, EF-Tu-2-2, EF-Tu-3-1, EF-Tu-3-2, EF-Tu-3-3, or EF-Tu-3-4 (Figure 2B). Four additional fragments were designed to more specifically determine the position of the epitope by decreasing the length of the peptide by one amino acid at a time from both sides of the sequence (Figure 2A). Western blotting showed that BD6 reacted with EF-Tu-4-1 and EF-Tu-4-2 but not with EF-Tu-4-3 or EF-Tu-4-4 (Figure 2B). Based on the results of western blotting, the epitope within B. melitensis EF-Tu that is recognized by BD6 was deduced to be 110QTREHIL116.
Figure 2. Identification of epitope recognized by McAb BD6. (A) Summary design of overlapping fragments of EF-Tu, with accurate position of epitope recognized by McAb BD6 deduced at 110Gln Thr Arg Glu His Ile leu116 in B. melitensis EF-Tu protein. (B) Analysis of various overlapping fusion proteins of EF-Tu expressed in E. coli BL21 (DE3) by western blotting using McAb BD6 as primary antibody.
Critical Residues Responsible for the Activity of BD6
To define the key residues contributing to the activity of epitope EF, seven mutant epitope peptides with GST tags were designed and separately expressed in BL21 before being screened by immunoblotting using anti-GST McAb as the primary antibody (Figure 3A). Western blotting showed that BD6 reacted with M-EF-113 and M-EF-114 but not with M-EF-110, M-EF-111, M-EF-112, M-EF-115, or M-EF-116 (Figure 3B).
Figure 3. Identification of the crucial residue of the epitope to McAb BD6. (A) Western blotting analysis of seven mutagenesis epitope peptides expressed in E. coli BL21 (DE3) using anti-GST McAb as primary antibody. (B) Western blotting analysis of seven mutagenesis epitope peptides by western blotting to confirmed central sequence of epitope, using McAb BD6 as primary antibody. (C,D) Indirect immunofluorescence assay (C) and flow cytometry (D) analysis yeast cells displayed seven mutagenesis EF-Tu proteins. (a) Yeast cell displaying P-EF-Tu-(Q110-A) protein; (b) yeast cell displaying P-EF-Tu-(T111-A) protein; (c) yeast cell displaying P-EF-Tu-(R112-A) protein; (d) yeast cell displaying P-EF-Tu-(E113-A) protein; (e) yeast cell displaying P-EF-Tu-(H114-A) protein; (f) yeast cell displaying P-EF-Tu-(I115-A) protein; (g) yeast cell displaying P-EF-Tu-(L116-A) protein; and (h) yeast cell displaying B. melitensis EF-Tu protein as positive control. BD6 as primary antibody and fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG [H + L] as secondary antibody.
To further confirm the key amino acid residues, seven mutant EF-Tu gene constructs containing alanine substitutions at single amino acid residues were generated by overlap PCR. The resulting EF-Tu proteins were individually displayed on the surface of yeast cells. Binding of BD6 to the mutant EF-Tu proteins on the yeast cell surfaces was then detected by fluorescence microscopy and using a cell analyzer. Indirect immunofluorescence assays showed strong immunofluorescence on the surface of yeast cells displaying P-EF-Tu-(E113A), P-EF-Tu-(H114A), and wild-type EF-Tu protein (Figures 3Cd,e,h). No immunofluorescence was detected for yeast cells displaying the remaining mutant EF-Tu proteins. Flow cytometry confirmed that BD6 recognized P-EF-Tu-(E113A), P-EF-Tu-(H114A), and wild-type EF-Tu protein, but did not bind to the other mutant proteins (Figure 3D). These results indicated that residues Q110, T111, R112, I115, and L116 were critical for binding of BD6 to the EF epitope. In contrast, substitutions at E113 and H114 had no effect on the binding of the McAb to the epitope.
Conservation of the Epitope Sequence Recognized by BD6
Sequence alignment of epitope motifs from different bacterial species found that the epitope sequence QTREHIL is highly conserved amongst a range of bacterial species (Figure 4A). However, a single amino acid (I115) difference was observed between bacterial and host epitope sequences (Figure 4A, blue box). The reactivity between BD6 and the human EF epitope (QTREHLL) was then analyzed. Western blotting showed that BD6 did not recognize the human peptide sequence (Figure 4B).
Figure 4. Analysis of the difference of epitope amino acids among different species. (A) Alignment of EF-Tu protein amino acid sequences surrounding the epitope region. The BD6 epitope amino acid residues are in red box. (B) Western blotting analysis of the reactivity between BD6 and QTREHLL (human). 1, GST-QTREHIL (B. melitensis) recombinant protein, positive control; 2, GST-QTREHLL (human) recombinant protein.
Antigenicity of Epitope EF
The 3-D structure of B. melitensis EF-Tu was predicted using the SWISS-MODEL online server (Figure 5A). The template is ancient sequence-reconstructed Elongation Factor Tu (SMTL ID: 6gfu. 1), with 99% query coverage and 86.89% identity. Structural analysis showed that the epitope formed part of an α-helix and was located in a region with a high antigenic index and high hydrophilicity (Figure 5B). These findings suggesting that epitope EF may be a vital B-cell epitope within the EF-Tu protein of B. melitensis. To confirm the antigenicity of epitope EF, mice were immunized with purified B. melitensis or mouse GST-tagged EF proteins (Figure 5C). Serum antibodies induced by the fusion proteins were then detected by ELISA (Figure 5D). Results showed significantly higher production of serum antibodies against the B. melitensis GST-EF epitope peptide compared with GST alone at both 0 and 7 days post-booster immunization (Figure 5D). There was no significant difference in antibody production between the mouse GST-EF peptide and GST-only immunization groups. These results indicated that the bacterial EF epitope sequence, QTREHIL, induced a high humoral immune response, and that residue I115 is likely to be the key amino acid residue for host recognition of self and non-self protein.
Figure 5. Identification of the immunogenicity of epitope EF. (A) Localization of the identified BD6 epitope in a partially predicted 3-D structure of B. melitensis EF-Tu protein is highlighted in an α-helix. (B) The antigenic index of EF-Tu protein was predicted by DNAstart and the epitope 110QTREHIL116 was located on a highlighted antigenic index region (red box). (C) SDS–PAGE analysis of purified GST, GST-EF (B. melitensis), GST-EF (mice) protein. (D) The level of serum antibody IgG immunized with GST-EF (B. melitensis), GST-EF (mice) protein was detected by ELISA on 0 day and 7 days post-second immunization. ∗∗p < 0.001 represents the significant difference compared with PBS group. (E) Dot-blot analysis of B. melitensis-infected mouse sera with synthetic epitope EF peptide as antigen. 1–5, B. melitensis-infected sera; 7–11, no-B. melitensis-infected sera; 6, BD6 McAb as positive control; 12, Membrane incubated without primary antibody as control.
Anti-epitope EF Peptide Antibodies Exist in B. melitensis-Infected Mouse Sera
Serum samples from B. melitensis-infected and control mice were examined using synthetic epitope peptide as the antigen (Figure 5E). Dot blot analysis showed that epitope EF reacted with sera from infected mice but not with samples from the uninfected control mice. These data suggested that the EF peptide may be an important antigen epitope in animal hosts.
Application of the BD6 Epitope in a Yeast Expression System
To examine whether epitope EF-tagged proteins could be successfully expressed in yeast, S. cerevisiae cells transformed with recombinant plasmid pCTCON2-EtMIC2-EF or PCTCON2-EtMIC2 were screened using an immunofluorescent labeling assay. Results showed that the green fluorescence was homogeneously distributed on the surface of yeast cells immuno-stained with anti-EtMIC2 McAb (Figure 6A). Flow cytometry showed that 63.1% of yeast cells displayed EtMIC2 on their surface, while 65.3% displayed EtMIC2-EF (Figure 6B). This result suggested that the epitope EF tag did not affect heterogenous gene expression in yeast cells.
Figure 6. Detection and immunoprecipitation (IP) of EF tag fused protein in yeast, human embryonic kidney cells (HEK-293) and chicken fibroblast cell line (DF1). (A) Immunofluorescence analysis of EtMIC2-EF (a) and EtMIC2 (b) were expressed in yeast cells, using anti-EtMIC2 McAb as primary antibody. Yeast transfected with empty vector as control (c). (B) Analyzed quantitative expression of EtMIC2-EF and EtMIC2 on the yeast cells surface by flow cytometry. NS, not significant (p > 0.05). (C) DF1 cells transfected with pEGFP–C1 and pEGFP–EF showed obvious fluorescence signals at 36 h post-transfection. (D) HEK-293 cells transfected with pEGFP–C1 and pEGFP–EF showed obvious fluorescence signals at 36 h post-transfection. (E,F) The level of expression in DF1 cell or HEK-293 transfected with pEGFP–C1 and pEGFP–EF was detected by western blot using anti-GFP McAb. GAPDH is loading control. (G) IP of analysis of transfected cell lysates using BD6 as a capture antibody in a pull-down assay. Only EGFP-EF was detected by IP using anti-GFP McAb. Mock normal cells.
Expression and Immunoprecipitation of the BD6 Epitope Tag in Mammalian and Avian Cell Expression Systems
Although the epitope EF-tag was successfully expressed in a yeast expression system, it was unclear whether EF-tagged fusion proteins could be expressed correctly and whether the tag could be of use in protein studies requiring mammalian and avian cell systems. Expression plasmid pEGFP-EF, containing an EF tag fused to the C-terminus of EGFP, was transfected into HEK-293 or DF1 cells and analyzed at 36 h post-transfection. The pEGFP-EF-transfected cells showed obvious green fluorescence signals, similar to those of the positive control (pEGFP-C1) (Figures 6C,D). Western blotting confirmed that there were no differences in expression between pEGFP-EF-transfected and pEGFP-C1-transfected cells (Figures 6E,F). These results indicated that the EF tag did not affect the expression or function of recombinant proteins in either mammalian or avian cell expression systems.
To investigate whether the EF tag and BD6 McAb could be used in immunoprecipitation assays, lysates from transfected cells were incubated with BD6 McAb, precipitated using protein G Sepharose, and detected using anti-GFP antibodies. Western blotting showed that the BD6 McAb captured EGFP-EF specifically, and did not pull down other proteins from pEGFP-C1-transfected or mock-infected cells (Figure 6G). These data therefore confirmed that the BD6 McAb and EF tag could be used in mammalian/avian expression systems and were also suitable for use in immunoprecipitation assays for studying protein-protein interactions.
EF-Tu proteins from some pathogenic bacteria play a pivotal role in protein synthesis as well as being novel moonlighting proteins involved in many cellular and disease processes (Marques et al., 1998; Alonso et al., 2002; Sharma et al., 2011; Jiang et al., 2016). Studies have found that membrane-expressed EF-Tu mediates cytoskeletal complex formation (Defeu Soufo et al., 2010; Matsubayashi et al., 2013) and acts as a virulence factor by binding to complement and fibronectin to facilitate infection (Kunert et al., 2007; Balasubramanian et al., 2008). Further studies have shown that EF-Tu can also mediate pathogen invasion (Nandan and Reiner, 2005; Barel et al., 2008) and help evade the host immune response (Matsubayashi et al., 2013). However, few studies have addressed the role of EF-Tu in Brucella species, mainly because there is a lack of specific tools for the identification of this protein. McAbs are a useful tool for identifying the function of proteins (Kivi et al., 2016). They can be used in protein subcellular localization studies (Liu et al., 2014), co-immunoprecipitation assays for examining interacting proteins (Verhelst et al., 2015), and for epitope screening (Arthur Huang et al., 2017), amongst other applications. In the present study, we generated a McAb, BD6, which specifically recognizes EF-Tu from B. melitensis. Using this novel McAb, other functions of the B. melitensis EF-Tu protein may be identified, including how it functions during the infection process and its involvement in evading the host immune response.
The epitope (i.e., antigenic determinant) is the pivotal part of an antigen for inducing an immune response. Well-defined epitopes and McAbs provide a platform for studying antigen structure and developing diagnostic methods and epitope vaccines. A recent study showed that the epitope of EF-Tu from Acidovorax avenae is the key sequence for inducing an immune reaction in rice (Furukawa et al., 2014). As a multifunction protein, EF-Tu is also an important antigen (Sharma et al., 2011; Matsubayashi et al., 2013; Wang et al., 2013). Following an immunoproteomic analysis of B. melitensis, Yang et al. (2011) showed that EF-Tu is a candidate immunogenic protein for developing a brucellosis subunit vaccine. To determine the key amino acid residues of B. melitensis EF-Tu, we identified the sequence of a linear B-cell epitope, 110QTREHIL116, in the B. melitensis EF-Tu protein. A dot blot assay confirmed that anti-EF peptide antibodies also exist in serum from B. melitensis-infected mice. Accordingly, the epitope EF is likely to be an important B-cell epitope, playing a major role in inducing an immune reaction and with potential for development as an epitope vaccine. Sequence alignment identified only a single amino acid (I115) difference between the B. melitensis and host EF peptide sequences. Immunization of mice showed that epitope EF can induce a humoral immune response generating highly specific serum antibodies, but that no reaction occurred following immunization with the mouse peptide (QTREHAL). Therefore, residue I115 is likely to be a key residue allowing host cells to recognize and differentiate between antigenic and endogenous EF-Tu proteins. This specificity of McAb BD6 provides a tool for studying the function and mechanism of B. melitensis EF-Tu. Through the application of blastp (BLASTP 2.9.0 +) online analysis on the NCBI website, the results showed that the EF tag is conserved in bacteria species when the parameter Max Target Sequences was set to 100. The epitope peptide was conserved among bacterial species, indicating that this McAb BD6 could also be used for identification of other bacterial pathogens.
Affinity tags have been widely used in the purification of recombinant or native proteins and in the exploration of protein function. Together with corresponding McAbs, epitope tags have diverse experimental applications, including western blot analysis, ELISA, co-immunoprecipitation, endogenous localization, and affinity purification (Kimple et al., 2013). Compared with larger affinity tags, such as maltose-binding protein and GST, epitope tags (between 6 and 22 amino acids in length) can minimize effects on the tertiary structures and biological activities of fusion proteins (Terpe, 2003). However, the most commonly used affinity epitope tags have some disadvantages, including sub-optimal affinity or specificity (England et al., 2015) and significant effects on protein expression (Noirclerc-Savoye et al., 2015) and crystallization (Xu et al., 2008). Liu et al. (2016) identified a 12-residue epitope using a McAb that is suitable for applications in bacterial, plant, and mammalian cell systems. However, the epitope is larger than Flag, HA, and Myc tag. In the present study, a 7-residue epitope recognized by BD6 was identified by western blotting. Alanine-scanning mutagenesis revealed that BD6 specifically recognizes its epitope peptide at five crucial amino acid residues. Indirect immunofluorescence and western blotting assays indicated that epitope EF could be used in yeast, mammalian, and avian expression systems as well as in immunoprecipitation assays for analysis of protein-protein interactions. Based on the small size of the epitope and the high specificity of BD6, epitope EF shows great potential for use as a novel epitope tag for exploring protein function.
In conclusion, we generated a McAb, BD6, which specifically recognizes bacterial EF-Tu proteins. After identifying the linear B-cell epitope, we examined the central sequence and immunogenicity of the epitope. The resulting sequence, 110QTREHIL116, is believed to be the first linear epitope identified in the B. melitensis EF-Tu protein. This work provides an important epitope for developing epitope vaccines and may be a powerful tool for studying the potential functions of the B. melitensis EF-Tu protein. The McAb BD6 is a useful tool for further investigation of the potential functions of the EF-Tu protein in pathogen-host interactions, and the epitope tag may be useful for application as a novel affinity tag to identify other bacterial pathogens, which is especially convenient for the identification of intracellular bacteria.
The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.
FW and XZ participated in the study design. NZ and YJ carried out the study and NZ drafted the manuscript. YJ, SM, and SL collected the important background information. All authors read and approved the final manuscript.
This work was supported by the Cattle Industrial Innovation Team of Shandong Modern Agricultural Industrial and Technical System (SDAIT-09-04), the Shangdong “Double Tops” program, the Collaborative Innovation Program of Shandong Higher Education Institutions (SDE  11), and the State Key Laboratory of Veterinary Biotechnology (SKLVBF2018-05).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
We thank Tamsin Sheen, Ph.D., from Liwen Bianji, Edanz Editing China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2019.01878/full#supplementary-material
Alonso, J. M., Prieto, M., and Parra, F. (2002). Genetic and antigenic characterisation of elongation factor Tu from Mycoplasma mycoides subsp. mycoides SC. Vet Microbiol. 89, 277–289. doi: 10.1016/s0378-1135(02)00258-4
Amimanan, P., Tavichakorntrakool, R., Fong-Ngern, K., Sribenjalux, P., Lulitanond, A., Prasongwatana, V., et al. (2017). Elongation factor Tu on Escherichia coli isolated from urine of kidney stone patients promotes calcium oxalate crystal growth and aggregation. Sci. Rep. 7:2953. doi: 10.1038/s41598-017-03213-x
Arthur Huang, K. Y., Chen, M. F., Huang, Y. C., Shih, S. R., Chiu, C. H., Lin, J. J., et al. (2017). Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat. Commun. 8:762. doi: 10.1038/s41467-017-00736-9
Balasubramanian, S., Kannan, T. R., and Baseman, J. B. (2008). The surface-exposed carboxyl region of Mycoplasma pneumoniae elongation factor Tu interacts with fibronectin. Infect. Immun. 76, 3116–3123.
Barel, M., Hovanessian, A. G., Meibom, K., Briand, J. P., Dupuis, M., and Charbit, A. (2008). A novel receptor - ligand pathway for entry of francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu. BMC Microbiol. 8:145. doi: 10.1186/1471-2180-8-145
Chen, Z., Wang, X., Zhao, N., Han, L., Wang, F., Li, H., et al. (2018). Improving the immunogenicity and protective efficacy of the EtMIC2 protein against eimeria tenella infection through random mutagenesis. Vaccine 36, 2435–2441. doi: 10.1016/j.vaccine.2018.03.046
Defeu Soufo, H. J., Reimold, C., Linne, U., Knust, T., Gescher, J., and Graumann, P. L. (2010). Bacterial translation elongation factor EF-Tu interacts and colocalizes with actin-like MreB protein. Proc. Natl. Acad. Sci. U.S.A.107, 3163–3168. doi: 10.1073/pnas.0911979107
Furukawa, T., Inagaki, H., Takai, R., Hirai, H., and Che, F. S. (2014). Two distinct EF-Tu epitopes induce immune responses in rice and Arabidopsis. Mol. Plant Microbe. Interact. 27, 113–124. doi: 10.1094/MPMI-10-13-0304-R
Hadji-Ghasemi, F., Gharagozlou, S., Ghods, R., Roohi, A., Khoshnoodi, J., and Shokri, F. (2003). Generation and characterization of a mouse monoclonal antibody with specificity similar to staphylococcal protein A (SPA). Hybrid. Hybridomics. 22, 33–39. doi: 10.1089/153685903321538062
Jiang, F., He, J., Navarro-Alvarez, N., Xu, J., Li, X., Li, P., et al. (2016). elongation factor tu and heat shock protein 70 are membrane-associated proteins from mycoplasma ovipneumoniae capable of inducing strong immune response in mice. PLoS One 11:e0161170. doi: 10.1371/journal.pone.0161170
Jonak, J. (2007). Bacterial elongation factors EF-Tu, their mutants, chimeric forms, and domains: isolation and purification. J. Chromatogr. B Analyt. Technol. Biomed Life Sci. 849, 141–153. doi: 10.1016/j.jchromb.2006.11.053
Kivi, G., Teesalu, K., Parik, J., Kontkar, E., Ustav, M. Jr, Noodla, L., et al. (2016). HybriFree: a robust and rapid method for the development of monoclonal antibodies from different host species. BMC Biotechnol. 16:2. doi: 10.1186/s12896-016-0232-6
Kunert, A., Losse, J., Gruszin, C., Huhn, M., Kaendler, K., Mikkat, S., et al. (2007). Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J. Immunol. 179, 2979–2988. doi: 10.4049/jimmunol.179.5.2979
Liu, H. L., Liu, Y. W., Shen, T. L., Hsu, C. H., and Chang, Y. C. (2016). Characterization and application of a common epitope recognized by a broad-spectrum C4 monoclonal antibody against capsid proteins of plant potyviruses. Appl. Microbiol. Biotechnol. 100, 1853–1869. doi: 10.1007/s00253-015-7116-x
Liu, Q., Chen, Z., Shi, W., Sun, H., Zhang, J., Li, H., et al. (2014). Preparation and initial application of monoclonal antibodies that recognize Eimeria tenella microneme proteins 1 and 2. Parasitol. Res. 113, 4151–4161. doi: 10.1007/s00436-014-4087-2
Marques, M. A., Chitale, S., Brennan, P. J., and Pessolani, M. C. (1998). Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect. Immun. 66, 2625–2631.
Matsubayashi, M., Teramoto-Kimata, I., Uni, S., Lillehoj, H. S., Matsuda, H., Furuya, M., et al. (2013). Elongation factor-1alpha is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum. J. Biol. Chem. 288, 34111–34120. doi: 10.1074/jbc.M113.515544
Mohan, S., Hertweck, C., Dudda, A., Hammerschmidt, S., Skerka, C., Hallstrom, T., et al. (2014). Tuf of Streptococcus pneumoniae is a surface displayed human complement regulator binding protein. Mol. Immunol. 62, 249–264. doi: 10.1016/j.molimm.2014.06.029
Nandan, D., and Reiner, N. E. (2005). Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1. Clin. Immunol. 114, 266–277. doi: 10.1016/j.clim.2004.07.017
Noirclerc-Savoye, M., Flayhan, A., Pereira, C., Gallet, B., Gans, P., Ebel, C., et al. (2015). Tail proteins of phage T5: investigation of the effect of the His6-tag position, from expression to crystallisation. Protein Expr. Purif. 109, 70–78. doi: 10.1016/j.pep.2015.02.003
Sharma, J., Mishra, B. B., Li, Q., and Teale, J. M. (2011). TLR4-dependent activation of inflammatory cytokine response in macrophages by francisella elongation factor Tu. Cell Immunol. 269, 69–73. doi: 10.1016/j.cellimm.2011.03.023
Sun, H., Wang, L., Wang, T., Zhang, J., Liu, Q., Chen, P., et al. (2014a). Display of Eimeria tenella EtMic2 protein on the surface of Saccharomyces cerevisiae as a potential oral vaccine against chicken coccidiosis. Vaccine 32, 1869–1876. doi: 10.1016/j.vaccine.2014.01.068
Sun, H., Wang, T., Zhang, J., Liu, Q., Wang, L., Chen, P., et al. (2014b). Display of heterologous proteins on the Saccharomyces cerevisiae surface display system using a single constitutive expression vector. Biotechnol. Prog. 30, 443–450. doi: 10.1002/btpr.1846
Sun, Y. G., Li, R., Xie, S., Qiao, S., Li, Q., Chen, X. X., et al. (2019). Identification of a novel linear B-cell epitope within the collagenase equivalent domain of porcine epidemic diarrhea virus spike glycoprotein. Virus Res. 266, 34–42. doi: 10.1016/j.virusres.2019.04.003
Tissot, A. C., Renhofa, R., Schmitz, N., Cielens, I., Meijerink, E., Ose, V., et al. (2010). Versatile virus-like particle carrier for epitope based vaccines. PLoS One 5:e9809. doi: 10.1371/journal.pone.0009809
Wang, F., Qiao, Z., Hu, S., Liu, W., Zheng, H., Liu, S., et al. (2013). Comparison of genomes of Brucella melitensis M28 and the B. melitensis M5-90 derivative vaccine strain highlights the translation elongation factor Tu gene tuf2 as an attenuation-related gene. Infect. Immun. 81, 2812–2818. doi: 10.1128/IAI.00224-13
Wolff, D. G., Castiblanco-Valencia, M. M., Abe, C. M., Monaris, D., Morais, Z. M., Souza, G. O., et al. (2013). Interaction of Leptospira elongation factor Tu with plasminogen and complement factor H: a metabolic leptospiral protein with moonlighting activities. PLoS One 8:e81818. doi: 10.1371/journal.pone.0081818
Xu, C. G., Fan, X. J., Fu, Y. J., and Liang, A. H. (2008). Effect of location of the His-tag on the production of soluble and functional buthus martensii karsch insect toxin. Protein Expr. Purif. 59, 103–109. doi: 10.1016/j.pep.2008.01.009
Yang, Y., Wang, L., Yin, J., Wang, X., Cheng, S., Lang, X., et al. (2011). Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine. Mol. Immunol. 49, 175–184. doi: 10.1016/j.molimm.2011.08.009
Keywords: monoclonal antibody, epitope, EF-Tu, affinity tag, Brucella melitensis
Citation: Zhao N, Jiang Y, Ming S, Liu S, Zhao X and Wang F (2019) Monoclonal Antibody Preparation and Epitope Identification for Brucella melitensis Elongation Factor Tu. Front. Microbiol. 10:1878. doi: 10.3389/fmicb.2019.01878
Received: 04 May 2019; Accepted: 30 July 2019;
Published: 13 August 2019.
Edited by:José Roberto Mineo, Federal University of Uberlândia, Brazil
Reviewed by:Marisa Mariel Fernandez, Institute of Studies on Humoral Immunity (IDEHU), Argentina
Dolores Correa, National Institute of Pediatrics (Mexico), Mexico
Copyright © 2019 Zhao, Jiang, Ming, Liu, Zhao and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.